Detection of large rearrangements in a hereditary pan-cancer panel using next-generation sequencing
暂无分享,去创建一个
T. Judkins | Debora Mancini-DiNardo | B. Roa | B. Morris | K. Brown | J. Kidd | Courtney Daniels | Jayson Holladay | Jonathan Craft | Kirsten Meek | R. Bernhisel
[1] H. Cox,et al. Identification of pathogenic retrotransposon insertions in cancer predisposition genes. , 2017, Cancer genetics.
[2] Satish Bhatnagar,et al. T E C H N I C a L a D V a N C E Open Access , 2022 .
[3] N. Gutin,et al. Design and validation of an oligonucleotide microarray for the detection of genomic rearrangements associated with common hereditary cancer syndromes , 2014, Journal of experimental & clinical cancer research : CR.
[4] C. Boland,et al. Inversion of exons 1–7 of the MSH2 gene is a frequent cause of unexplained Lynch syndrome in one local population , 2014, Familial Cancer.
[5] B. Casini,et al. Early-onset colorectal cancer patients without family history are “at very low risk” for lynch syndrome , 2014, Journal of experimental & clinical cancer research : CR.
[6] Diana Eccles,et al. Cancer risks for BRCA1 and BRCA2 mutation carriers: results from prospective analysis of EMBRACE. , 2013, Journal of the National Cancer Institute.
[7] V. Gatta,et al. Use of the MLPA Assay in the Molecular Diagnosis of Gene Copy Number Alterations in Human Genetic Diseases , 2012, International journal of molecular sciences.
[8] Leif E. Peterson,et al. Characterization of BRCA1 and BRCA2 mutations in a large United States sample. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[9] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[10] D. Easton,et al. Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.
[11] Matthew P. Goetz,et al. NCCN CLINICAL PRACTICE GUIDELINES IN ONCOLOGY , 2019 .
[12] S. Friedman,et al. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2017. , 2017, Journal of the National Comprehensive Cancer Network : JNCCN.
[13] Hilde van der Togt,et al. Publisher's Note , 2003, J. Netw. Comput. Appl..
[14] D. Easton,et al. Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.